A little over a year ago, LifeMine Therapeutics laid off staff and put its fungus-based platform on ice to focus its dwindling resources on its lead asset. Now, the Massachusetts biotech is shaking off the cobwebs thanks in part to substantial investments from billionaires Bill Gates and Jeff Bezos.
